Hanna P Lesch

Title: Innovator Spotlight: Hanna P. Lesch

Introduction

Hanna P. Lesch is a notable inventor based in Kuopio, Finland, with an impressive portfolio of six patents. Her work focuses on advancing biotechnological processes, particularly in the realms of viral vector production and recombinant polypeptide manufacturing.

Latest Patents

Hanna's recent patents demonstrate her commitment to innovation in the life sciences. One of her key patents is the "Viral vector assay and vector," which outlines a process for assaying viral vectors produced through large-scale manufacturing. This innovative system integrates three different assays, which can be utilized independently or collectively, ensuring the produced vectors maintain acceptable levels of purity and potency.

Another significant patent is her "Method of manufacturing a recombinant polypeptide." In this patent, Hanna describes modifications made to a commercially available adherent cell culture bioreactor to enhance cell productivity while minimizing contamination. The adjustments she has made lead to a slower flow rate of the cell culture medium, which results in a remarkable increase in the productivity of the cultured adherent cells. Additionally, she has developed a new sampling manifold configuration that reduces contamination risks during the sampling process.

Career Highlights

Hanna P. Lesch's contributions to biotechnology and her innovative approaches have positioned her as a leader in her field. Her work at Trizell Limited has allowed her to spearhead advancements that directly impact the efficiency and safety of viral vector manufacturing and recombinant protein production.

Collaborations

Throughout her career, Hanna has collaborated with esteemed colleagues, including Piia Kristiina Valonen and Eva Kristiina Rasanen. These partnerships in Trizell Limited have fostered an environment of creativity and collaboration, enabling groundbreaking research and development in biotechnological applications.

Conclusion

Hanna P. Lesch's dedication to innovation and her significant contributions to the field of biotechnology mark her as an exemplary inventor. With her recent patents addressing critical challenges in viral vector production and cell culture processes, she continues to influence the industry positively. Her work serves as an inspiration for aspiring inventors and researchers dedicated to finding solutions to complex problems in science and technology.